ArticleKidney medicine2026
Changing Pattern of Peritoneal Dialysis-Related Fungal Peritonitis: A 21-Year Single-Center Experience.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: Fungal peritonitis (FP) in peritoneal dialysis is rare but associated with catastrophic outcomes. This study evaluated the longitudinal evolution of FP incidence during 2004-2024, with particular interest in the effects of antifungal prophylaxis, which was introduced in 2016, on the development of FP and the risk factors for FP-associated death. Study Design: Retrospective cohort study. Setting & Participants: Sixty-two episodes of FP in 62 patients undergoing peritoneal dialysis who experienced FP at our center between January 2004 and December 2024. Exposure: Antifungal prophylaxis with oral fluconazole 100 mg/d. Outcomes: Incidences of overall, secondary, and primary FP; risk factors for FP-associated death. Analytical Approach: Linear by linear association; Poisson regression; logistic regression. Results: The average FP rate was 0.0065 episodes/patient-year. The annual FP rates significantly decreased over the 21 years ( Limitations: Single-center, observational study. Conclusions: Incidences of overall FP and secondary FP declined at our center, advocating the effectiveness of antifungal prophylaxis in programs with a low baseline FP rate. Primary FP represented the major subtype after implementation of antifungal prophylaxis, and high mortality remained an issue. A greater comorbid condition burden, as well as certain species of causative fungi, were associated with risks of death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.